July 13, 2020 / 12:41 PM / 24 days ago

PerkinElmer forecasts 12% rise in second-quarter revenue

(Reuters) - Diagnostic kit maker PerkinElmer Inc (PKI.N) on Monday forecast a 12% rise in second-quarter revenue on better-than-expected demand for its COVID-19 testing products.

The company expects $190 million in revenue from the sale of testing kits, it said in a statement. (reut.rs/3fpXkan)

PerkinElmer’s serological test to identify COVID-19 antibodies received an approval for emergency use from the U.S. Food and Drug Administration in May.

Analysts on average were expecting revenue of $668.9 million, according to data from Refinitiv I/B/E/S.

The company is expected to report second-quarter results on July 28.

Reporting by Trisha Roy in Bengaluru; Editing by Anil D'Silva

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below